Diagnostics Announces Closing Of Registered Direct Offering Of Common Stock
18/09/2025 22:27
Sept 18 (Reuters) - Co-Diagnostics Inc CODX.O: CO-DIAGNOSTICS, INC. ANNOUNCES CLOSING OF $3.8 MILLION REGISTERED DIRECT OFFERING OF COMMON STOCK PRICED AT-THE-MARKET UNDER NASDAQ RULES Source text: ID:nPn1YzBrPa Further company coverage: CODX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Co-Diagnostics
See all newsDiagnostics' Joint Venture Cosara Diagnostics Announces Publication Of Peer-Reviewed Hpv Screening Study Using Cosara's Saragene® Test
Diagnostics - Cosara To Initiate Sales Activities Across India And South Asia
Diagnostics’ Brian Brown Stepped Down As CFO Effective September 2
Diagnostics Q2 revenue rises slightly amid international expansion
Diagnostics - Amends Equity Distribution Agreement With Maxim Group For Common Stock Sale - SEC Filing